Brian Casey and Wayne Forrest[email protected]Clinical NewsPull linear MRI contrast from market, European group saysIn a stunning development, a European Union regulatory body on Friday recommended that four gadolinium-based contrast agents for MRI scans be pulled off the market due to concerns about gadolinium remaining in the body years after scans occur. The agents affected include some of the most widely used contrast products in medical imaging.March 9, 2017Page 1 of 1Top StoriesCardiovascular RadiologyMRI casts light on patient outcome after heart attackIncreased volume of fat tissue around the heart tends can be associated with greater myocardial damage after a heart attack, German researchers have reported.Advanced Visualization3D-printed prostheses bring hope in conflict zonesMRIMRI proves effective for tracking results of obesity interventionsCTLung cancer screening: How Croatia does itMRIAI comes under scrutiny in Swedish prostate MRI study